A Case Report of Gastrointestinal Hemorrhage and Perforation During Apatinib Treatment of Gastric Cancer

Apatinib is a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2, which shows good efficacy and safety in clinical trials for chemotherapy-refractory gastric cancer patients. Till now, there is no case report after apatinib came in the market. We presented a 55-y...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao-Fen, Tan, Yi-Nuo, Cao, Ying, Xu, Jing-Hong, Zheng, Shu, Yuan, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616867/
https://www.ncbi.nlm.nih.gov/pubmed/26426663
http://dx.doi.org/10.1097/MD.0000000000001661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616867/
https://www.ncbi.nlm.nih.gov/pubmed/26426663
http://dx.doi.org/10.1097/MD.0000000000001661

Ejemplares similares